Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 8671 | 18.73 |
09:34 ET | 325 | 18.59 |
09:36 ET | 1985 | 18.7 |
09:38 ET | 4975 | 18.68 |
09:39 ET | 929 | 18.7 |
09:41 ET | 7461 | 18.715 |
09:43 ET | 800 | 18.74 |
09:45 ET | 11513 | 18.75 |
09:48 ET | 21000 | 18.86 |
09:50 ET | 5060 | 18.85 |
09:52 ET | 800 | 18.84 |
09:54 ET | 8605 | 18.87 |
09:56 ET | 1494 | 18.88 |
09:57 ET | 4817 | 18.85 |
09:59 ET | 2555 | 18.85 |
10:01 ET | 3054 | 18.91 |
10:03 ET | 3791 | 18.88 |
10:06 ET | 3376 | 18.9 |
10:08 ET | 2111 | 18.89 |
10:10 ET | 54369 | 18.82 |
10:12 ET | 2059 | 18.87 |
10:14 ET | 7632 | 18.85 |
10:15 ET | 700 | 18.8 |
10:17 ET | 5327 | 18.82 |
10:19 ET | 9364 | 18.84 |
10:21 ET | 10254 | 18.85 |
10:24 ET | 8757 | 18.91 |
10:26 ET | 3042 | 18.95 |
10:28 ET | 35051 | 19 |
10:30 ET | 15330 | 18.98 |
10:32 ET | 16601 | 18.97 |
10:33 ET | 7407 | 18.99 |
10:35 ET | 13819 | 19 |
10:37 ET | 14481 | 18.96 |
10:39 ET | 6146 | 19.01 |
10:42 ET | 6260 | 19.005 |
10:44 ET | 6109 | 19.005 |
10:46 ET | 12475 | 19.02 |
10:48 ET | 2248 | 19.02 |
10:50 ET | 3866 | 18.98 |
10:51 ET | 13491 | 18.95 |
10:53 ET | 24977 | 19 |
10:55 ET | 3195 | 18.99 |
10:57 ET | 1581 | 18.99 |
11:00 ET | 2200 | 18.99 |
11:02 ET | 22191 | 19.03 |
11:04 ET | 4321 | 19.0012 |
11:06 ET | 8952 | 18.98 |
11:08 ET | 4048 | 19 |
11:09 ET | 36294 | 18.97 |
11:11 ET | 4128 | 18.99 |
11:13 ET | 6676 | 18.98 |
11:15 ET | 2629 | 18.96 |
11:18 ET | 3200 | 18.94 |
11:20 ET | 4378 | 18.96 |
11:22 ET | 12290 | 18.945 |
11:24 ET | 5309 | 18.93 |
11:26 ET | 3441 | 18.99 |
11:27 ET | 6065 | 18.96 |
11:29 ET | 3191 | 18.97 |
11:31 ET | 1000 | 18.98 |
11:33 ET | 2866 | 19 |
11:36 ET | 997 | 18.99 |
11:38 ET | 1000 | 19.01 |
11:40 ET | 2773 | 19.04 |
11:42 ET | 61756 | 19.065 |
11:44 ET | 14299 | 19.08 |
11:45 ET | 5392 | 19.1 |
11:47 ET | 2853 | 19.09 |
11:49 ET | 3061 | 19.065 |
11:51 ET | 7860 | 19.1 |
11:54 ET | 1615 | 19.11 |
11:56 ET | 18016 | 19.06 |
11:58 ET | 11346 | 19.07 |
12:00 ET | 8443 | 19.05 |
12:02 ET | 3762 | 19.08 |
12:03 ET | 3311 | 19.07 |
12:05 ET | 3534 | 19.05 |
12:07 ET | 1608 | 19.06 |
12:09 ET | 4005 | 19.08 |
12:12 ET | 19074 | 19.0304 |
12:14 ET | 13745 | 19.03 |
12:16 ET | 3152 | 19.07 |
12:18 ET | 3051 | 19.075 |
12:20 ET | 5404 | 19.09 |
12:21 ET | 2652 | 19.05 |
12:23 ET | 2209 | 19.05 |
12:25 ET | 2628 | 19.05 |
12:27 ET | 5147 | 19.03 |
12:30 ET | 4034 | 19.0228 |
12:32 ET | 3877 | 19.01 |
12:34 ET | 4702 | 19 |
12:36 ET | 22791 | 19 |
12:38 ET | 80095 | 18.97 |
12:39 ET | 7259 | 18.965 |
12:41 ET | 9518 | 18.99 |
12:43 ET | 3204 | 19.02 |
12:45 ET | 4425 | 19.04 |
12:48 ET | 3700 | 19.03 |
12:50 ET | 3705 | 19.02 |
12:52 ET | 4594 | 19.01 |
12:54 ET | 1533 | 19.01 |
12:56 ET | 1712 | 19.03 |
12:57 ET | 7417 | 19.01 |
12:59 ET | 1400 | 19.05 |
01:01 ET | 300 | 19.05 |
01:03 ET | 1800 | 19.025 |
01:06 ET | 1312 | 19.05 |
01:08 ET | 6873 | 19.06 |
01:10 ET | 2128 | 19.07 |
01:12 ET | 2642 | 19.075 |
01:14 ET | 4326 | 19.07 |
01:15 ET | 3352 | 19.04 |
01:17 ET | 4333 | 19.06 |
01:19 ET | 3845 | 19.05 |
01:21 ET | 3189 | 19.04 |
01:24 ET | 5465 | 19.03 |
01:26 ET | 4077 | 19.045 |
01:28 ET | 600 | 19.03 |
01:30 ET | 2405 | 19.08 |
01:32 ET | 2253 | 19.06 |
01:33 ET | 1520 | 19.06 |
01:35 ET | 12736 | 19.04 |
01:37 ET | 4261 | 19.02 |
01:39 ET | 2526 | 19.04 |
01:42 ET | 3144 | 19.1 |
01:44 ET | 5927 | 19.06 |
01:46 ET | 9369 | 19.1 |
01:48 ET | 4200 | 19.08 |
01:50 ET | 2008 | 19.05 |
01:51 ET | 3510 | 19.05 |
01:53 ET | 3503 | 19.08 |
01:55 ET | 6639 | 19.07 |
01:57 ET | 1970 | 19.07 |
02:00 ET | 4200 | 19.09 |
02:02 ET | 34781 | 19.07 |
02:04 ET | 438 | 19.06 |
02:06 ET | 15491 | 19.05 |
02:08 ET | 1900 | 19.06 |
02:09 ET | 5015 | 19.04 |
02:11 ET | 700 | 19.055 |
02:13 ET | 1000 | 19.065 |
02:15 ET | 5273 | 19.085 |
02:18 ET | 4755 | 19.11 |
02:20 ET | 2282 | 19.09 |
02:22 ET | 1634 | 19.045 |
02:24 ET | 3088 | 19.08 |
02:26 ET | 900 | 19.1 |
02:27 ET | 1545 | 19.1 |
02:29 ET | 4271 | 19.1 |
02:31 ET | 1243 | 19.1 |
02:33 ET | 2843 | 19.1 |
02:36 ET | 4256 | 19.1 |
02:38 ET | 1468 | 19.09 |
02:40 ET | 1500 | 19.1 |
02:42 ET | 3254 | 19.1 |
02:44 ET | 6061 | 19.115 |
02:45 ET | 1500 | 19.115 |
02:47 ET | 2463 | 19.1 |
02:49 ET | 2499 | 19.11 |
02:51 ET | 2909 | 19.135 |
02:54 ET | 1682 | 19.145 |
02:56 ET | 300 | 19.13 |
02:58 ET | 9461 | 19.14 |
03:00 ET | 2884 | 19.12 |
03:02 ET | 4789 | 19.105 |
03:03 ET | 2300 | 19.105 |
03:05 ET | 5683 | 19.105 |
03:07 ET | 1308 | 19.1088 |
03:09 ET | 2085 | 19.105 |
03:12 ET | 4382 | 19.1 |
03:14 ET | 63648 | 19.08 |
03:16 ET | 110644 | 19.06 |
03:18 ET | 5599 | 19.04 |
03:20 ET | 4378 | 19.0642 |
03:21 ET | 900 | 19.07 |
03:23 ET | 3690 | 19.08 |
03:25 ET | 2026 | 19.11 |
03:27 ET | 7380 | 19.105 |
03:30 ET | 5002 | 19.1 |
03:32 ET | 6141 | 19.1 |
03:34 ET | 5874 | 19.105 |
03:36 ET | 2800 | 19.13 |
03:38 ET | 3441 | 19.15 |
03:39 ET | 5658 | 19.16 |
03:41 ET | 11130 | 19.1388 |
03:43 ET | 1600 | 19.135 |
03:45 ET | 19275 | 19.145 |
03:48 ET | 10113 | 19.14 |
03:50 ET | 14788 | 19.125 |
03:52 ET | 35141 | 19.205 |
03:54 ET | 34710 | 19.165 |
03:56 ET | 27652 | 19.135 |
03:57 ET | 51855 | 19.17 |
03:59 ET | 319105 | 19.14 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 3.1B | -1,487.2x | --- |
Azenta Inc | 3.2B | -22.0x | --- |
PTC Therapeutics Inc | 2.6B | -4.4x | --- |
Guardant Health Inc | 3.9B | -8.4x | --- |
Amicus Therapeutics Inc | 3.0B | -20.6x | --- |
Novavax Inc | 2.3B | -5.4x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.36 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,487.2x |
Price/Sales (TTM) | 3.8 |
Price/Cash Flow (TTM) | 342.7x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.